Infectious Disease Drugs Market
Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of ... Read More
Therapies related to the JAK and PI3K signaling pathways have the potential to target diseases such as cancer and inflammatory diseases, and no suitable drugs are currently available. Current therapies can reduce the burden of disease, but they cannot be cured.
This report contains market size and forecasts of JAK and PI3K Signaling Pathway in Global, including the following market information:
Global JAK and PI3K Signaling Pathway Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global JAK and PI3K Signaling Pathway market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
PI3K Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of JAK and PI3K Signaling Pathway include Bayer HealthCare Pharmaceuticals, AbbVie, AstraZeneca, Curis, Daiichi Sankyo, Exelixis, Genentech, Infinity Pharmaceuticals and Merck & Co., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the JAK and PI3K Signaling Pathway companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global JAK and PI3K Signaling Pathway Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global JAK and PI3K Signaling Pathway Market Segment Percentages, by Type, 2021 (%)
PI3K
Janus Kinase Therapies (Inhibitors)
PI3K Therapies (Inhibitors)
Signal Transduction Biomarkers for JAK and PI3K
Global JAK and PI3K Signaling Pathway Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global JAK and PI3K Signaling Pathway Market Segment Percentages, by Application, 2021 (%)
Cancer
Inflammatory Diseases
Cardiac Ailments
Others
Global JAK and PI3K Signaling Pathway Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global JAK and PI3K Signaling Pathway Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies JAK and PI3K Signaling Pathway revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies JAK and PI3K Signaling Pathway revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer HealthCare Pharmaceuticals
AbbVie
AstraZeneca
Curis
Daiichi Sankyo
Exelixis
Genentech
Infinity Pharmaceuticals
Merck & Co.
Rigel Pharmaceuticals
TG Therapeutics
Sanofi Oncology
Vertex Pharmaceuticals
WILEX AG
Infectious Disease Drugs are drugs that relieve symptoms, resolve symptoms, or block the route of ... Read More
Quantum Dot LED Lighting enables tunable light conversion technology.
This report c ... Read More
Etch Process is used in microfabrication to chemically remove layers from the surface of a wafer ... Read More
The term Inorganic Polymer was first widely used in the 1950s, when the aircraft and aerospace in ... Read More